[
  {
    "ts": null,
    "headline": "Gilead Sciences (NasdaqGS:GILD) Faces Shareholder Proposals As Stock Rises 5%",
    "summary": "Gilead Sciences (NasdaqGS:GILD) has been the center of investor activism, facing several shareholder proposals, including the separation of the Chairman and CEO roles and developing a comprehensive human rights policy. The company advised voting against these proposals, slated for discussion at the upcoming annual meeting. Despite broader market challenges like the Dow's 1.7% decline and inflation concerns, Gilead's stock rose 18% over the last quarter, potentially buoyed by its robust Q4...",
    "url": "https://finnhub.io/api/news?id=d2ec35ff87d25c53aeea261704899a65debaa5e170936332a3f854f1f16d2994",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743182630,
      "headline": "Gilead Sciences (NasdaqGS:GILD) Faces Shareholder Proposals As Stock Rises 5%",
      "id": 133523855,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (NasdaqGS:GILD) has been the center of investor activism, facing several shareholder proposals, including the separation of the Chairman and CEO roles and developing a comprehensive human rights policy. The company advised voting against these proposals, slated for discussion at the upcoming annual meeting. Despite broader market challenges like the Dow's 1.7% decline and inflation concerns, Gilead's stock rose 18% over the last quarter, potentially buoyed by its robust Q4...",
      "url": "https://finnhub.io/api/news?id=d2ec35ff87d25c53aeea261704899a65debaa5e170936332a3f854f1f16d2994"
    }
  }
]